| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $20.2M | -2.8% | -20.0% |
| SG&A Expense | $7.1M | +10.6% | -17.0% |
| Operating Income | -$27.3M | -0.4% | +19.3% |
| Income Tax | $0 | — | — |
| Net Income | -$21.7M | +5.5% | +23.4% |
| EPS (Basic) | -$0.29 | +6.5% | +25.6% |
| EPS (Diluted) | -$0.29 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $60.1M | +12.5% | +5.5% |
| Short-term Investments | $222.2M | -5.9% | -1.7% |
| Current Assets | $289.3M | -2.5% | -0.3% |
| Total Assets | $427.2M | -4.7% | -19.7% |
| Current Liabilities | $19.0M | +0.3% | -15.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$67.1M | — | — |
| Capital Expenditures | $648K | — | — |
| Investing Cash Flow | $99.2M | — | — |
| Financing Cash Flow | $77K | — | — |
| Free Cash Flow | -$67.7M | — | — |
| +25.6% |
| $89.3M |
| -1.4% |
| -11.7% |
| Stockholders' Equity | $337.9M | -5.5% | -21.6% |